Speech-derived Digital Biomarkers Study

Clinical trial NCT06994767 · COMPLETED

Trial details

NCT number: NCT06994767
Sponsor: Hackensack Meridian Health
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Mild Cognitive Impairment (MCI)Alzheimer Disease

Start date: 2025-05-19
Primary completion: 2026-01-09
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.